Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 9Colorectal Neoplasms 7Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Multiple Myeloma 6Melanoma 6Wilms Tumor 4Pancreatic Neoplasms 4Neoplasms 4Lymphoma 4Hematologic Neoplasms 4Head and Neck Neoplasms 4Plasmablastic Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Hodgkin Disease 3Glioblastoma 3Ependymoma 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Burkitt Lymphoma 3Astrocytoma 3Triple Negative Breast Neoplasms 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Medulloblastoma 2

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × 30 days × Clear all
NCT01220583 2026-05-27

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Radiation Therapy Oncology Group

Phase 2 Active not recruiting
252 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡